JUPITER NEUROSCIENCES, INC. Increase (Decrease) in Prepaid Expenses, Other
JUPITER NEUROSCIENCES, INC. (JUNS) reported Increase (Decrease) in Prepaid Expenses, Other of $113.83 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-04-01
- JUPITER NEUROSCIENCES, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was $113.83K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|
| 2024-12-31 | $113.83K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |